Lymph node research pioneers’ new approach to vaccine design for the most vulnerable

Published on January 17, 2024

The Oxford Experimental Medicine Clinical Research Facility (EMCRF) at NDORMS has received its first volunteers as part of the LEGACY03 trial to improve vaccine design for different age groups.